Jazz Pharmaceuticals JAZZ Effective Income Tax Rate Reconciliation, FDII, Amount
Effective Income Tax Rate Reconciliation, FDII, Amount at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's effective income tax rate reconciliation, fdii, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's effective income tax rate reconciliation, FDII, amount?
- Jazz Pharmaceuticals (JAZZ) reported effective income tax rate reconciliation, FDII, amount of $7.16M in Q4 2025.
- How has Jazz Pharmaceuticals's effective income tax rate reconciliation, FDII, amount changed year-over-year?
- Jazz Pharmaceuticals's effective income tax rate reconciliation, FDII, amount decreased by 27.5% year-over-year, from $9.87M to $7.16M.
- What is the long-term trend for Jazz Pharmaceuticals's effective income tax rate reconciliation, FDII, amount?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's effective income tax rate reconciliation, FDII, amount has grown at a 70.1% compound annual growth rate (CAGR), from $3.42M to $28.62M.
- What does effective income tax rate reconciliation, FDII, amount mean?
- The dollar value of tax deductions related to income derived from foreign sales.
- How do you interpret effective income tax rate reconciliation, FDII, amount?
- Higher values indicate successful utilization of FDII incentives, which reduces the overall tax liability.
- How does effective income tax rate reconciliation, FDII, amount compare across companies?
- Relevant for U.S.-based multinational corporations with significant export-oriented intellectual property.